Longitudinal surveillance of the molecular evolution of methicillin-resistant Staphylococcus aureus isolates from pediatric patients in Shanghai, China, from 2013 to 2022

X. Pan, Jiao Zhang, Fen Pan, Chun Wang, Huihong Qin, Fangyuan Yu, Tiandong Zhang, Wenxin Liu, Qianyue Wu, Zhan Ma, Wenhao Weng, Liang Chen, Fangyou Yu, Hong Zhang, Bingjie WangmSystems 2025 · DOI

TL;DR

This study provides a decade-long genomic surveillance of MRSA in pediatric patients in Shanghai, revealing significant shifts in dominant strains and their associated resistance and virulence profiles. The findings highlight the dynamic nature of MRSA evolution in this vulnerable population and underscore the need for ongoing monitoring.

What Problem Does This Paper Address?

Methicillin-resistant Staphylococcus aureus (MRSA) is a major global health threat. While much research has focused on adult MRSA infections or specific infection sites, there's a significant knowledge gap regarding the long-term evolution of MRSA specifically within pediatric populations. Understanding these dynamics is crucial for developing effective prevention and treatment strategies for children, who may have different susceptibility patterns and exposure risks compared to adults. This paper aims to fill this gap by comprehensively analyzing MRSA isolates from pediatric patients in Shanghai over a 10-year period.

Methods

The researchers employed whole-genome sequencing (WGS) to analyze 492 MRSA isolates collected from a pediatric hospital in Shanghai between 2013 and 2022. Standard WGS analysis pipelines were used, including:

  • DNA Extraction and Sequencing: Standard kits were used for DNA extraction, followed by Illumina NovaSeq sequencing.
  • Bioinformatic Analysis: Raw sequencing data were filtered and assembled into contigs. Multilocus sequence typing (MLST) was performed using PubMLST. Spa and SCCmec typing were predicted using SpaFinder and SCCmecFinder. Virulence factor genes and antimicrobial resistance genes were identified using ABRicate with VFDB and CARD databases. Prokka was used for gene annotation.
  • Phylogenetic Analysis: A core-genome alignment of 1,702 core genes was generated using Panaroo, and a maximum-likelihood phylogenetic tree was constructed using FastTree.
  • Antimicrobial Susceptibility Testing: Broth microdilution was used to determine resistance to a panel of antibiotics, following CLSI guidelines.
  • Statistical Analysis: Standard statistical tests (Pearson's chi-squared, Fisher's exact, Student's t-test) were used to analyze the data.

Datasets

The study utilized 492 non-duplicate MRSA clinical isolates collected from a tertiary pediatric hospital in Shanghai between 2013 and 2022. These isolates represent a longitudinal dataset spanning a decade. The raw sequence data for these isolates have been deposited in the Sequence Read Archive under BioProject accession no. PRJNA1211827.

Key Insights and Ideas

  • Shifting Dominance: The study reveals a dynamic shift in the predominant MRSA lineages over the decade. While ST59 was initially dominant, ST398 gradually increased in prevalence and eventually matched or exceeded ST59. This suggests an evolving landscape of MRSA clones in pediatric settings.
  • Clone-Specific Resistance and Virulence: Different MRSA lineages exhibit distinct antibiotic resistance profiles and carry specific virulence factors. For example, ST59 showed higher resistance to erythromycin and clindamycin, while ST398 had lower resistance and fewer virulence determinants. This highlights the importance of understanding lineage-specific characteristics for targeted treatment.
  • Spa-SCCmec Evolution: The study observed dynamic changes in spa-SCCmec structures within prevalent STs. For instance, within ST59, the t437-IV subtype declined, and t172-IV became more prevalent. In ST398, the t011-V subtype emerged and rapidly became dominant. This indicates ongoing molecular adaptation within key MRSA clones.
  • Community vs. Hospital Association: While MRSA cases could be classified as community-associated (CA-MRSA) or hospital-associated (HA-MRSA), the study found significant differences in demographic characteristics and susceptibility patterns between these groups, underscoring distinct epidemiological roles.
  • Impact of COVID-19: An unusual epidemic trend observed in 2020, with a peak in MRSA prevalence followed by a sharp decline, is linked to the COVID-19 pandemic and associated non-pharmaceutical interventions, which affected sample collection patterns (e.g., reduced upper respiratory tract samples).

Key Results

  • Predominant Lineages: The most prevalent sequence types (STs) identified were ST59 (37.4%), ST398 (22.4%), ST88 (5.7%), and ST22 (5.5%).
  • ST398's Rise: ST398's proportion increased from 6.0% in 2013 to 34.0% in 2017, eventually matching or exceeding ST59's prevalence in most years.
  • Spa Type Dynamics: The t437-IV subtype within ST59 declined, while t172-IV increased. For ST398, t011-V became dominant after its emergence in 2014.
  • Antibiotic Resistance: ST59 showed high resistance to erythromycin and clindamycin. ST398 exhibited relatively low resistance. Clindamycin resistance was significantly higher in CA-MRSA compared to HA-MRSA.
  • Virulence Factors: Panton-Valentine leucocidin (PVL) was more common in ST338 and ST1232. Toxic shock syndrome toxin (TSST) was associated with ST1 and ST5. CC398 carried fewer virulence genes compared to other clones.
  • OS-MRSA: Three oxacillin-susceptible MRSA (OS-MRSA) isolates carrying the mecA gene were identified.

Limitations and Future Work

  • Geographic Specificity: The study is limited to a single pediatric hospital in Shanghai, China. While it provides valuable insights into the local MRSA landscape, the findings may not be directly generalizable to other regions or populations.
  • Adult vs. Pediatric Differences: The authors note that there are many differences in MRSA isolates between adults and children, suggesting that future research should continue to focus on pediatric-specific epidemiology.
  • Future Work: The study emphasizes the imperative for continuous, vigilant monitoring of MRSA within the pediatric demographic to track its evolving genetic landscape. Further research could explore the specific host-pathogen interactions that drive the success of certain MRSA clones in children and investigate the impact of interventions on MRSA evolution. The identification of novel STs also warrants further investigation.

Summary updated

Abstract

Methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) has emerged as a significant global health concern. Previous research on MRSA epidemiology has predominantly focused on adult populations or targeted specific infection sites, while there was limited research on the long-term evolution of MRSA from the pediatric population. This study addresses this knowledge gap by conducting a comprehensive, 10-year surveillance of pediatric MRSA isolates using whole-genome sequencing. We characterized the molecular typing, as well as the phenotypic and genotypic antimicrobial resistance profiles, and virulence factors present in MRSA isolates obtained from children. Our results highlight the imperative for continuous, vigilant monitoring of MRSA within the pediatric demographic to track its evolving genetic landscape.
BibTeX
@inproceedings{pan2025longitudinal,
  author = {X. Pan and Jiao Zhang and Fen Pan and Chun Wang and Huihong Qin and Fangyuan Yu and Tiandong Zhang and Wenxin Liu and Qianyue Wu and Zhan Ma and Wenhao Weng and Liang Chen and Fangyou Yu and Hong Zhang and Bingjie Wang},
  title = {{Longitudinal surveillance of the molecular evolution of methicillin-resistant <i>Staphylococcus aureus</i> isolates from pediatric patients in Shanghai, China, from 2013 to 2022}},
  booktitle = {mSystems},
  year = {2025},
  doi = {10.1128/msystems.00371-25},
}
Figure